Surmodics (STU:SU6) Institutional Ownership : 34.18% (As of Jun. 25, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Surmodics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Surmodics's institutional ownership is 34.18%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Surmodics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Surmodics's Float Percentage Of Total Shares Outstanding is 79.60%.

Surmodics Institutional Ownership Historical Data

The historical data trend for Surmodics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surmodics Institutional Ownership Chart

Surmodics Historical Data

The historical data trend for Surmodics can be seen below:

	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	34.42	36.58	33.92	33.06	35.17	34.79	34.59	34.33	34.20	34.18

Surmodics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Surmodics (STU:SU6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surmodics Inc (STU:SU6) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

SRDX:USA SU6:Germany

Address

9924 West 74th Street, Eden Prairie, MN, USA, 55344

Website

https://www.surmodics.com

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

Surmodics (STU:SU6) Headlines

No Headlines